Rare diseases
Investigational molecules
Locations
Study on Tildrakizumab and Etanercept for Children Aged 6 to 17 with Moderate to Severe Plaque Psoriasis
SpainStudy on the Long-Term Safety of Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years
SpainStudy on Dinutuximab Beta with Chemotherapy for Children and Teens with Newly Diagnosed High-Risk Neuroblastoma
SpainStudy on the Safety and Effects of Sparsentan for Children with Proteinuric Kidney Diseases
SpainStudy on Efgartigimod for Children Aged 2-17 with Generalized Myasthenia Gravis
SpainStudy on the Safety and Effectiveness of Fluocinolone Acetonide Implant for Children Aged 6-17 with Recurrent Non-Infectious Uveitis in the Eye's Posterior Segment
SpainStudy on Phospholipid Fraction from Porcine Lung for Premature Infants with Respiratory Distress Syndrome (RDS)
SpainStudy on the Effectiveness and Safety of Vedolizumab for Children with Chronic Pouchitis Using a Drug Combination
SpainStudy on Clobetasol Propionate and Prednisolone Acetate for Treating Eye Inflammation After Cataract Surgery in Children Aged 0-3 Years
SpainStudy of Durvalumab alone and in combination with Tremelimumab in children with advanced solid tumors and blood cancer
SpainStudy on Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years
SpainStudy on Apremilast for Treating Oral Ulcers in Children with Behçet's Disease
SpainClinical research plays a vital role in developing safe and effective treatments for younger patients. Pediatric clinical trials are trials designed specifically for infants, children, and adolescents. They help researchers understand how new therapies, vaccines, or medical procedures work in younger populations and ensure that treatments are safe and appropriate for their age group.
Children are not simply smaller versions of adults. Their bodies grow and develop, which means medications may work differently than they do in adults. For this reason, therapies must be carefully studied in pediatric populations.
Another important reason for pediatric clinical trials is that some diseases occur primarily or exclusively in children. Certain genetic conditions, developmental disorders, and rare pediatric diseases affect only young patients. Without dedicated research involving children and adolescents, it would be difficult to develop treatments specifically designed for these conditions.
Pediatric research also helps doctors determine:
Participants in pediatric clinical trials may include infants, children, and teenagers depending on the trial design. Each trial has specific eligibility criteria based on age, health condition, and medical history.
Because participants are minors, the process always involves:
This ensures that families fully understand the purpose of the research, the procedures involved, and any potential risks or benefits.
Safety is the highest priority in pediatric clinical trials. These trials follow strict ethical and regulatory standards in Europe and internationally. Research protocols are reviewed by ethics committees and regulatory authorities to ensure that the risks are minimized and justified by the potential benefits of the research.
Children participating in clinical trials are monitored closely by qualified healthcare professionals throughout the entire process. Families receive detailed information about trial procedures, medical monitoring, and the right to withdraw from the trial at any time.
Our search platform allows parents and guardians to explore pediatric clinical trials available in different regions. Using the search tool, families can find trials based on factors such as age group, medical condition, and location.
Clinical trials for children and adolescents are essential for advancing pediatric medicine. By participating in research, families contribute to the development of safer and more effective treatments for young patients today and in the future.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
